Publications 2024

Lam YT, Papon JF, Alexandru M, Anagiotos A, Armengot M, Boon M, Burgess A, Calmes D, Crowley S, Dheyauldeen SAD, Emiralioglu N, Erdem Eralp E, van Gogh C, Gokdemir Y, Haarman EG, Harris A, Hayn I, Ismail-Koch H, Karadag B, Kempeneers C, Kieninger E, Kim S, Lorent N, Ozcelik U, Pioch C et al. (2024)
Association between upper and lower respiratory disease among patients with primary ciliary dyskinesia: an international study
ERJ Open Res, 10 (2)
DOI 10.1183/23120541.00932-2023, PubMed 38444659

Publications 2023

Goutaki M, Lam YT, Alexandru M, Anagiotos A, Armengot M, Boon M, Burgess A, Caversaccio N, Crowley S, Dheyauldeen SAD, Emiralioglu N, Erdem E, van Gogh C, Gunaydin O, Haarman EG, Harris A, Hayn I, Ismail-Koch H, Karadag B, Kempeneers C, Kim S, Lorent N, Ozcelik U, Pioch C, Poirrier AML et al. (2023)
Characteristics of Otologic Disease Among Patients With Primary Ciliary Dyskinesia
JAMA Otolaryngol Head Neck Surg, 149 (7), 587-596
DOI 10.1001/jamaoto.2023.0841, PubMed 37166807

Jørgensen OJ, Steineger JE, Hillarp A, Pareli Wåland E, Holme PA, Heimdal K, Dheyauldeen S (2023)
Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management
Laryngoscope Investig Otolaryngol, 9 (1), e1196
DOI 10.1002/lio2.1196, PubMed 38362186

Lam YT, Papon JF, Alexandru M, Anagiotos A, Armengot M, Boon M, Burgess A, Caversaccio N, Crowley S, Dheyauldeen SAD, Emiralioglu N, Erdem E, Gogh CV, Gokdemir Y, Gunaydın O, Haarman EG, Harris A, Hayn I, Ismail-Koch H, Karadag B, Kempeneers C, Kim S, Lorent N, Ozcelik U, Pioch C et al. (2023)
Lack of Correlation of Sinonasal and Otologic Reported Symptoms With Objective Measurements Among Patients With Primary Ciliary Dyskinesia: An International Study
Clin Exp Otorhinolaryngol, 16 (4), 407-412
DOI 10.21053/ceo.2023.01130, PubMed 38056830

Lam YT, Papon JF, Alexandru M, Anagiotos A, Armengot M, Boon M, Burgess A, Crowley S, Dheyauldeen SAD, Emiralioglu N, Erdem Eralp E, van Gogh C, Gokdemir Y, Gunaydın O, Haarman EG, Harris A, Hayn I, Ismail-Koch H, Karadag B, Kempeneers C, Kim S, Latzin P, Lorent N, Ozcelik U, Pioch C et al. (2023)
Sinonasal disease among patients with primary ciliary dyskinesia: an international study
ERJ Open Res, 9 (3)
DOI 10.1183/23120541.00701-2022, PubMed 37228283

Wiedmann M, Olesrud I, Lashkarivand A, Dheyauldeen S, Heck A, Berg-Johnsen J, Dahlberg D (2023)
Endoscopic four-hands technique for pituitary tumours
Tidsskr Nor Laegeforen, 143 (9)
DOI 10.4045/tidsskr.22.0693, PubMed 37341404

Publications 2020

Hui D, Steineger JE, Akre H, Osnes T, Dheyauldeen S (2020)
Otorhinolaryngologists and the SARS-CoV-2 virus
Tidsskr Nor Laegeforen, 140 (10)
DOI 10.4045/tidsskr.20.0423, PubMed 32602325

Hui D, Steineger JE, Akre H, Osnes T, Dheyauldeen S (2020)
Otorhinolaryngologists and the SARS-CoV-2 virus
Tidsskr. Nor. Laegeforen., 140 (10), 966-967

Publications 2019

Steineger J, Geirdal AØ, Osnes T, Heimdal KR, Dheyauldeen S (2019)
Intranasal bevacizumab injections improve quality of life in HHT patients
Laryngoscope, 130 (5), E284-E288
DOI 10.1002/lary.28179, PubMed 31287573

Publications 2018

Eguíluz-Gracia I, Malmstrom K, Dheyauldeen SA, Lohi J, Sajantila A, Aaløkken R, Sundaram AYM, Gilfillan GD, Makela M, Baekkevold ES, Jahnsen FL (2018)
Monocytes accumulate in the airways of children with fatal asthma
Clin Exp Allergy, 48 (12), 1631-1639
DOI 10.1111/cea.13265, PubMed 30184280

Steineger J, Osnes T, Heimdal K, Dheyauldeen S (2018)
Long-term experience with intranasal bevacizumab therapy
Laryngoscope, 128 (10), 2237-2244
DOI 10.1002/lary.27147, PubMed 29469958

Steineger J, Ueland T, Aukrust P, Michelsen A, Osnes T, Heimdal K, Dheyauldeen S (2018)
Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis
Laryngoscope, 129 (1), E44-E49
DOI 10.1002/lary.27548, PubMed 30329172

Publications 2017

Dollner R, Lorentz Larsen P, Dheyauldeen S, Steinsvåg S (2017)
A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu
Allergy Rhinol (Providence), 8 (3), 148-156
DOI 10.2500/ar.2017.8.0216, PubMed 29070272

Steineger J, Merckoll E, Slåstad JM, Eriksen EF, Heimdal K, Dheyauldeen S (2017)
Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report
Laryngoscope, 128 (3), 593-596
DOI 10.1002/lary.26722, PubMed 28671294

Publications 2016

Eguíluz-Gracia I, Bosco A, Dollner R, Melum GR, Lexberg MH, Jones AC, Dheyauldeen SA, Holt PG, Bækkevold ES, Jahnsen FL (2016)
Rapid recruitment of CD14(+) monocytes in experimentally induced allergic rhinitis in human subjects
J Allergy Clin Immunol, 137 (6), 1872-1881.e12
DOI 10.1016/j.jaci.2015.11.025, PubMed 26851967

Publications 2012

Dheyauldeen S, Østertun Geirdal A, Osnes T, Vartdal LS, Dollner R (2012)
Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose
Laryngoscope, 122 (6), 1210-4
DOI 10.1002/lary.23303, PubMed 22565282

Geirdal AØ, Dheyauldeen S, Bachmann-Harildstad G, Heimdal K (2012)
Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study
Am J Med Genet A, 158A (6), 1269-78
DOI 10.1002/ajmg.a.35309, PubMed 22529055

Geirdal AØ, Dheyauldeen S, Bachmann-Harildstad G, Heimdal K (2012)
Living with hereditary haemorrhagic telangiectasia: coping and psychological distress - a cross-sectional study
Disabil Rehabil, 35 (3), 206-13
DOI 10.3109/09638288.2012.690500, PubMed 22671535

Publications 2011

Dheyauldeen S, Abdelnoor M, Bachmann-Harildstad G (2011)
The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study
Am J Rhinol Allergy, 25 (4), 214-8
DOI 10.2500/ajra.2011.25.3616, PubMed 21819756

Publications 2010

Fodstad P, Dheyauldeen S, Rinde M, Bachmann-Harildstad G (2010)
Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
Ann Hematol, 90 (5), 611-2
DOI 10.1007/s00277-010-1063-5, PubMed 20824275